Note: This is an archived Handbook entry from 2011.
|Dates & Locations:|| |
This subject has the following teaching availabilities in 2011:Semester 2, Parkville - Taught on campus.
Timetable can be viewed here. For information about these dates, click here.
|Time Commitment:||Contact Hours: 3 x one hour lectures per week (total contact hours: 36) |
Total Time Commitment: 120 hours
|Prerequisites:|| BSc students: |
Study Period Commencement:
Study Period Commencement:
|Recommended Background Knowledge:||None|
|Non Allowed Subjects:|| This subject cannot be taken if credit has been previously obtained for 534-304 Pharmacology of Therapeutic Substances. |
|Core Participation Requirements:||It is University policy to take all reasonable steps to minimise the impact of disability upon academic study and reasonable steps will be made to enhance a student’s participation in the University’s programs. |
This subject requires all students to actively and safely participate in laboratory activities. Students who feel their disability may impact upon their participation are encouraged to discuss this with the subject coordinator and the Disability Liaison Unit:
CoordinatorAssoc Prof Christine Wright, Assoc Prof James Ziogas
Assoc Prof James Ziogas:
Assoc Prof Christine Wright:
Ms Hong Nguyen
Cancer, disorders of the immune system, cardiovascular diseases and acute and chronic lung disorders are the most common types of afflictions affecting people worldwide. This subject will examine the medicines that have been developed, or are currently being researched, to treat these diverse conditions. This subject will present the scientific basis of present and likely future treatments of cancer, allergy, acute and chronic inflammation, infection, autoimmunity and transplant rejection, as well as of hypertension, heart failure, cardiovascular atheromatous disease and metabolic syndrome. You will examine current knowledge of the pathogenesis of these disorders and the mechanisms of action of the major classes of drugs used to treat immune disorders, cancer, cardiovascular and respiratory diseases will be considered in the context of these systems and processes. The importance of biotechnology to these therapeutic areas will also be considered.
|Breadth Options:|| |
This subject potentially can be taken as a breadth subject component for the following courses:
You should visit learn more about breadth subjects and read the breadth requirements for your degree, and should discuss your choice with your student adviser, before deciding on your subjects.
|Fees Information:||Subject EFTSL, Level, Discipline & Census Date|
|Generic Skills:||By the end of this unit students will: |
|Notes:||This subject is available to students enrolled in the BSc, Biomedicine degree.|
Bachelor of Science |
Biomedical Biotechnology (specialisation of Biotechnology major) |
Science credit subjects* for pre-2008 BSc, BASc and combined degree science courses
Download PDF version.